Quick Answer
MAIA Biotechnology, Inc. reported Operating Income of -$24.27 million for fiscal year 2025.
MAIA Biotechnology, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$24.27M | -43.1% |
| 2024 | -$16.96M | +16.0% |
| 2023 | -$20.18M | -24.8% |
| 2022 | -$16.18M | -107.7% |
| 2021 | -$7.79M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$9.36M | -123.5% | -81.2% |
| June 30, 2025 | -$5.17M | -35.4% | +4.8% |
| March 31, 2025 | -$5.43M | -37.4% | -29.5% |
| September 30, 2024 | -$4.19M | +15.5% | -9.8% |
| June 30, 2024 | -$3.82M | +18.2% | +3.4% |
| March 31, 2024 | -$3.95M | +5.6% | +20.3% |
| September 30, 2023 | -$4.96M | +2.7% | -6.2% |
| June 30, 2023 | -$4.66M | -35.5% | -11.5% |
- MAIA Biotechnology, Inc. showed a decrease of -43.1% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, MAIA Biotechnology, Inc.’s operating income has declined by 211.7% (from -$7.79 million to -$24.27 million).
- The most recent figure is from MAIA Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: